Fear memories are acquired through neuronal plasticity, an orchestrated sequence of events regulated at circuit and cellular levels. The conventional model of fear acquisition assumes unimodal (for example, excitatory or inhibitory) roles of modulatory receptors in controlling neuronal activity and learning. Contrary to this view, we show that protease-activated receptor-1 (PAR1) promotes contrasting neuronal responses depending on the emotional status of an animal by a dynamic shift between distinct G proteincoupling partners. In the basolateral amygdala of fear-naive mice PAR1 couples to Ga q/11 and Ga o proteins, while after fear conditioning coupling to Ga o increases. Concurrently, stimulation of PAR1 before conditioning enhanced, but afterwards it inhibited firing of basal amygdala neurons. An initial impairment of the long-term potentiation (LTP) in PAR1-deficient mice was transformed into an increase in LTP and enhancement of fear after conditioning. These effects correlated with more frequent 2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl)propanoic acid (AMPA) receptor-mediated miniature post synaptic events and increased neuronal excitability. Our findings point to experience-specific shifts in PAR1-G protein coupling in the amygdala as a novel mechanism regulating neuronal excitability and fear.
INTRODUCTION
Seven transmembrane G protein-coupled receptors (GPCRs) constitute the largest family of signaling proteins and are activated by a variety of natural ligands. 1 On agonist binding GPCRs transduce cellular signals through a wide range of G proteins, linked to diverse biochemical pathways. Over the past decade a concept of invariable, static association of distinct GPCRs with predetermined G proteins has been challenged. It has been demonstrated that different synthetic ligands acting at the same receptor can elicit qualitatively different biochemical and cellular responses 2 by stabilizing GPCRs in different conformational states [3] [4] [5] and activating alternative transduction cascades. Optogenetic studies show that spatiotemporally precise control over intracellular signaling processes in discrete brain regions could serve to control higher behavioral functions in mammals. 6 Directing neuronal signaling through distinct transduction pathways in the nucleus accumbens of mice by using lightactivated, genetically-engineered GPCRs elicits contrasting reward-related behaviors in the conditioned place preference paradigm. 6 These experiments raise a fascinating possibility that GPCRs exhibit input-specific intracellular signaling by endogenous agonists, which could serve as a mechanism for experienceinduced plasticity, emotion and learning in the mammalian brain.
Protease-activated receptors (PARs) are a family of GPCRs activated through proteolysis within their extracellular N-terminal domain, exposing a tethered ligand that acts as an agonist at the receptor. 7 The best characterized member of this class, proteaseactivated receptor-1 (PAR1), can be cleaved by several native proteases, such as thrombin, tPA, plasmin, factor X or activated protein C, 8 that have distinct substrate specificities. Thus, on PAR1 cleavage, a different N-terminal of the receptor is generated, consistent with distinct proteases eliciting contrasting cellular responses. 8 The above findings indicate that PAR1 might be subject to agonist-directed signaling by the distinct proteasegenerated endogenous ligands.
Extracellular proteases in the amygdala and hippocampus are key regulators of neuronal activity leading to fear and anxiety. [9] [10] [11] [12] Spatially and temporally controlled release of proteases at excitatory synapses [9] [10] [11] [12] [13] [14] [15] modulates neuronal activity by cleaving membrane receptors, latent growth factors or adhesion molecules. 16, 17 These proteases also activate PAR1, 18, 19 a GPCR previously linked to excitatory synaptic transmission and learning. 13, 19 Here we show that PAR1 elicits contrasting neuronal responses and determines state-dependent neuronal network properties depending on the fear status of the animal by a dynamic control of PAR1 coupling to distinct G protein subtypes. Thus, biased GPCR signaling can serve as a fundamental mechanism of experience-induced neuronal plasticity in the mammalian brain, controlling neuronal responses, emotion and learning.
Fear conditioning PAR1
þ / þ or PAR1 À / À mice were placed in the conditioning chamber and received three conditioned stimulus-unconditioned stimulus pairings. The last 2 s of the tone (conditioned stimulus, 30 s, 2.8 kH, 85 dB) was paired with the footshock (unconditioned stimulus, 2 s, 0.4 mA) delivered through a grid floor and then the mice were moved to their home cage. In the 'unpaired' group the tone and footshock were delivered in a random manner. Cued conditioning was evaluated 48 h after training in a novel context (chamber with flat plastic floor and walls) for 2 min, after which the conditioned stimulus was delivered (2 min, 2.8 kHz, 85 dB) and freezing monitored. Data were analyzed using FreezeView software (Coulbourn Instruments, Whitehall, PA, USA).
Pain threshold
Each behavioral experiment was performed on a separate cohort of mice. PAR1
þ / þ and PAR1 À / À mice were subjected to a series of mild footshocks of increasing intensities (in 0.05 mA increments) and behavioral reaction was measured as previously described. 21 Novel object recognition The mice were placed in a 50 Â 50 Â 50 cm 3 Plexiglas box and left free to explore two objects for 5 min. The time of exploration of each object was recorded (head facing the object within 3 cm). At the end of the session the mice were put back to their home cage. After 1.5 and 24 h, one of the objects was replaced with an unfamiliar object and the mice were retested and time spent in exploring each object was recorded.
Elevated-plus maze
The elevated-plus maze test was performed as previously described. 9 The apparatus consisted of four non-transparent white Plexiglas arms: two enclosed arms (50 Â 10 Â 30 cm 
Western blotting
Their brains were removed and brain regions dissected from a coronal slice approx À 0.58 to À 2.3 mm relative to bregma. Samples from the hypothalamus medulla and cerebellar cortex were taken from the remaining tissue. Samples were homogenized 10 (see Supplementary Material for details) and the protein concentration adjusted. Reduced and denatured samples were subjected to SDS-polyacrylamide gel electrophoresis, transferred onto nitrocellulose membrane and blocked in TBST-milk (TBS, 0.1% Tween 20, 5% skim milk) for 1 h at room temperature. The membrane was probed with a rabbit anti-PAR1 (gift of Dr M Runge, 1:1000, 41C, overnight), rabbit anti-Ga q/11 antiserum (1:500 in TBST 5% milk) 22 or mouse anti-Ga o antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA, 1:500 in TBST 5% milk) followed by a compatible horseradish peroxidase-labeled secondary antibodies (both at 1:1000, 1 h at room temperature). The signal was normalized to actin. Luminescence was detected using a western blot luminal reagent and photographic film. The band intensities were measured using Scion Image (Scion Corp, Frederick, MD, USA).
Immunohistochemistry
The brains were fixed in 4% paraformaldehyde (PFA) overnight. Seventy micrometer-thick coronal free-floating sections were blocked with goat serum in phosphate-buffered saline (1:500 for 4 h, room temperature) and incubated with rabbit anti-PAR1 (1:500, 41C for 4 h), followed by the addition of mouse anti-neuron-specific nuclear protein (Millipore, Billerica, MA, USA, 1:200, 41C, overnight) and chicken anti-glial fibrillary acidic protein (Abcam, Cambridge, UK, 1:1000, 41C, overnight) to the same wells. To examine the level of c-Fos and phospho-CREB, separate sections were incubated with anti-c-Fos (Cell Signaling Technology Inc., Danvers, MA, USA, 1:200) or anti-phospho-CREB antibodies (Cell Signaling, 1:200), respectively. After several washes, the sections were incubated with the appropriate AlexaFluor 488, 546, 647 or Cy3-labeled secondary antibodies (Life Technologies Ltd, Paisley, UK or Abcam, all at 1:500, 41C, overnight). 4',6-Diamidino-2-phenylindole (pseudocolored gray) was used to visualize cell nuclei in conjunction with PAR1, neuron-specific nuclear protein and glial fibrillary acidic protein labeling. Sections in which the primary antibodies were omitted served as controls. The images were collected using LSM5 Exciter confocal microscope (Carl Zeiss Ltd, Cambridge, UK).
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Stereotaxic injections
Mice were bilaterally implanted with stainless-steel guide cannulae (26-gauge; Plastics One, Roanoke, VA, USA) aimed above the basolateral complex of the amygdala (1.5 mm posterior to bregma, 3.5 lateral and 4.0 ventral). After 1 week the mice were injected with SCH79797 (1 mM, 0.5 ml over 15 min) or vehicle (1:4 DMSO in artificial cerebrospinal fluid composed of 10 mM HEPES, 140 mM NaCl, 2.8 mM KCl, 1 mM MgCl 2 *6H 2 O, 2 mM CaCl 2 *2H 2 O, 10 mM glucose; pH 7.3) using the injection cannulae (33-gauge, projecting 0.75 mm) followed by fear conditioning. After the experiment, a small amount of bromophenol blue was injected to visualize the guide and injection cannulae tracks, the brains were sectioned and the cannulae placement was determined histologically.
Electrophysiology
Coronal slices containing the amygdala (400 mm for extracellular recordings or 300 mm for whole-cell recordings) were prepared from 8-12-weeksold PAR1
À / À or PAR þ / þ mice (see Supplementary Material for details). The mice were left undisturbed (naive), and subjected to the unpaired protocol or fear conditioning 48 h prior to the recordings.
Extracellular recordings in the lateral-basal pathway were made using a bipolar tungsten electrode (World Precision Instruments, Hertfordshire, UK) and glass microelectrodes (1-2 mO) filled with artificial cerebrospinal fluid. Several field potential traces were averaged to create a template and only the responses matching the template were analyzed. LTP was elicited by two trains of high-frequency tetanic stimulation (100 Hz, 1 s, 10-s interval) repeated 4 times at 3-min intervals. The recordings were amplified, filtered (10 kHz) and digitized (50 kHz).
Whole-cell recordings (see Supplementary Material for details) were made from somata of principal neurons of the basal nucleus of the amygdala. Principal neurons and interneurons were distinguished by their morphological and electrophysiological properties. 24 A maximum series resistance of 10-15 MO was tolerated and neurons with a resting membrane potential below À 50 mV were used. In current-clamp recordings the membrane potential was kept at À 80 mV (or À 40 mV where indicated). Input resistance and instantaneous spike frequency were derived from traces in which cells were injected with 200 ms current pulses ( À 100 to þ 600 pA; 50-pA increments). In order to record mEPSCs, TTX (1 mM; LATOXAN, Valence, France) and picrotoxin (100 mM; Sigma-Aldrich Company Ltd., Dorset, UK) were routinely included in the extracellular solution. The cell membrane was clamped at À 70 mV and at the end of each experiment mEPSCs were blocked with 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) (10 mM) to confirm they were mediated by AMPA receptors. To study miniature inhibitory postsynaptic currents, the cell membrane was clamped at À 70 mV. TTX (1 mM), AP-V (50 mM) and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) (10 mM; Tocris Bioscience, Bristol, UK) were routinely added to the extracellular solution. At the end of each experiment miniature inhibitory postsynaptic currents were blocked with picrotoxin (100 mM) to confirm they were GABA A -mediated.
Statistical analysis
Statistical analysis was performed using Statistica and GraphPad Prism. All values are expressed as means ± s.e.m. Student's t-test (for two groups) or analysis of variance for multiple comparisons followed by Tukey's post test was used as appropriate. P values of less than 0.05 were considered significant.
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RESULTS
PAR1 is enriched in mouse amygdala neurons
PARs are abundant in the brain, but their region-, circuit-and cell type-specific expression varies among species, 25, 26 suggesting species-specific functions. To better understand the role of PAR1 in the mouse central nervous system, we examined the presence of PAR1 in different brain regions by western blotting and found the highest levels in the basolateral amygdala (381 ± 68% enrichment relative to the hypothalamus; n ¼ 3 per brain region;
Figures 1a-c). Cortical expression was almost equally prominent (351±14%), while the thalamic and medulla levels were moderate (244 ± 23 and 252 ± 37%). PAR1 protein expression in the hippocampus, cerebellum and hypothalamus were the lowest (172±68%, 162±26% and 100±11%, respectively).
We next examined the pattern of PAR1 expression by immunohistochemistry. We found PAR1-positive cells in most regions of a mouse brain, with strong staining in the basolateral complex of the amygdala (n ¼ 5; Figure 1d þ / þ mice and PAR1 levels measured by western blotting (representative blots in a). The PAR1 band was not observed in PAR1
animals (b). The highest expression of PAR1 (normalized to b-actin levels) was detected in the amygdala, and the lowest in the hypothalamus (quantification in c; n ¼ 3 per brain region). Quadruple staining for PAR1 (d, h, j; green), neuronal marker NeuN (e, i; red), astrocyte marker glial fibrillary acidic protein (GFAP, f, i, j; far-red pseudocolored blue) and 4' ,6-Diamidino-2-phenylindole (g) was performed using coronal brain sections containing the amygdala. Immunohistochemistry revealed the majority of PAR1-positive cells within the basal nucleus co-localizing with NeuN (neuron-specific nuclear protein), indicative of their neuronal phenotype (h, quantified in l, n ¼ 5 mice). A weaker expression was occasionally observed in astrocytes (j, quantified in l). PAR1 signal was not observed when the primary antibody was omitted (k). Schematic representation of the study timeline and design (m). Various experimental combinations of the above were used as indicated in the text. Data shown as mean±s.e.m. (a) Western blotting demonstrated a 40% decrease in the amygdala PAR1 levels 5 min after fear conditioning, consistent with its cleavage by proteases (n ¼ 4 per group). PAR1 levels were back to normal 48 h later. Field potential amplitude (normalized to the maximum FP for each slice) recorded in the basal nucleus as a function of stimulus intensity applied to the lateral nucleus (input-output relationship; electrode placement shown in b) was similar in PAR1 þ / þ and PAR1 À / À mice (c). Tetanic stimulation (asterisks in d-f, h) resulted in a stable LTP in naive PAR1 þ / þ (d; black symbols), which lasted more than 2 h and was depressed in PAR1 À / À mice (red symbols). Fear conditioning caused a reversal of LTP in PAR1 À / À animals, which was approximately twofold higher than in PAR1 þ / þ mice during the course of the experiment (e). When the tone and footshock were delivered in a random manner the increase in the early phase of LTP in PAR1 À / À mice persisted, while the increase in the L-LTP was no longer observed (f). Individual representative traces at the baseline (1), 30 s (2) and 2 h post-tetanus (3) are shown as insets in d-f. Amygdala slices from PAR1 þ / þ and PAR1 À / À mice were perfused with picrotoxin to block GABA A receptors. The picrotoxin-induced increase in the field potential amplitude recorded in the basal nucleus of the amygdala was similar in both genotypes (g). Moreover, blocking the inhibitory input did not affect the impairment in the late phase of LTP observed in PAR1
À / À mice (h), indicating that GABAergic mechanisms in the amygdala are not affected by the deletion of the PAR1 gene. Please note an inhibitory effect of picrotoxin on post-tetanic potentiation equally pronounced in both genotypes. n ¼ 6-8 per group. Data are shown as mean±s.e.m. LA -lateral amygdala, BLA -basal amygdala, MeA -medial amygdala, CA -central amygdala.
performed multi-label immunohistochemistry using astrocytespecific (anti-glial fibrillary acidic protein) or neuron-specific (anti-neuron-specific nuclear protein) antibodies together with an anti-PAR1 immunoglobulin. We found that 92.9 ± 3.6% of PAR1-positive cells colocalized with neuron-specific nuclear protein, indicative of their neuronal phenotype (n ¼ 5; Figures 1d-l). PAR1 expression was most prominent in cell bodies and neuronal processes. Immunohistochemistry revealed weak expression of PAR1 in a small subpopulation of astrocytes (Figures 1f and j).
PAR1 is cleaved during conditioning and bidirectionally regulates long-term potentiation (LTP) and fear We first examined whether PAR1 is cleaved during fear conditioning in the basolateral amygdala. Western blotting showed that the density of a band recognized by an antibody raised against the extracellular portion of PAR1 decreased shortly after conditioning (but not after the unpaired protocol; n ¼ 4 per group, Po0.05) and returned to normal within 48 h (Figure 2a) , indicative of PAR1 cleavage and its subsequent replacement.
The basal nucleus of the amygdala serves as an important site of plasticity in fear conditioning and is involved in the acquisition of conditioned stimuli. [27] [28] [29] To study the role of PAR1 in amygdalar plasticity, we induced LTP in the lateral-basal amygdala pathway 30 of fear-naive PAR1 þ / þ and PAR1 À / À mice (Figure 2b ). Basal synaptic transmission was indistinguishable between genotypes ( Figure 2c) . However, the absence of PAR1 impaired LTP in this pathway in fear-naive animals (Figure 2d ; n ¼ 6 animals, n ¼ 8 slices per group, Po0.01 at 120 min). This reduction was not due to an enhancement of inhibitory mechanisms, 31 because neither basal excitability (Figure 2g ) nor the decrease in LTP (Figure 2h ; n ¼ 6, n ¼ 6-8, Po0.01 at 120 min) was affected by the GABA A receptor antagonist picrotoxin in PAR1 À / À compared to PAR1 þ / þ animals. Miniature inhibitory postsynaptic currents in whole-cell voltage clamp experiments showed similar frequency and amplitude between PAR1
þ / þ and PAR1 À / À mice in the basal amygdala neurons (Supplementary Figures S1 and 2 ), confirming that GABAergic inhibition was unaffected in PAR1 À / À animals. Fear learning liberates extracellular proteases 11, 12 and promotes cleavage of PAR1 in the amygdala (Figure 2a) , so we next investigated the contribution of PAR1 to fear-related neuronal plasticity. We subjected PAR1
þ / þ and PAR1 À / À mice to a mild fear conditioning protocol and induced LTP in the lateral-basal pathway. In contrast to fear-naive conditions, we found a twofold increase in LTP in PAR1 À / À mice as compared to PAR1
þ / þ animals ( Figure 2e ; n ¼ 6, n ¼ 8 per group, Po0.001 and Po0.01 for 60 and 120 min, respectively). To examine whether the above changes could be attributed to learning or rather stress-related alterations in neuronal physiology, we subjected mice to an unpaired conditioning protocol and induced LTP. Late phase of LTP (L-LTP) was defined based on its protein synthesis dependence 30 (Supplementary Figure S3) . The increase in the L-LTP in PAR1 À / À mice was due to fear learning (no change observed following the unpaired protocol; n ¼ 6, n ¼ 7 per group, P40.05 between PAR1
þ / þ and PAR1 À / À mice at 120 min), although the rise in the early phase of LTP was footshock-dependent (Po0.0001 at 30 s, Figure 2f ).
Electrically evoked LTP is often occluded by the 'LTP-like changes' induced by the conditioning procedure (see Supplementary Figure  S4 À / À mice, we measured tone-associated freezing following fear conditioning. In contrast to earlier studies, 13 we used a mild conditioning protocol resulting in B30% freezing in wild-type mice to detect either enhancement or reduction in fear learning in PAR1
À / À mice. Two-way analysis of variance revealed a strong effect of conditioning (F (1, 48) Figure 3 . Enhancement of conditioned fear by genetic or pharmacological disruption of PAR1. PAR1 þ / þ or PAR1 À / À mice were subjected to fear conditioning and amygdala-dependent memory tested two days later. The fear conditioning-related increase in amygdalar L-LTP in PAR1
À / À mice (see Figure 2e ) was accompanied by the increase in the amygdala-dependent fear measured as a percentage of time spent immobile (average values and representative movement traces recorded during fear retrieval in a-c). When exposed to the tone (time indicated as the red line on the x-axis in a-b) PAR1
À / À mice froze significantly more than PAR1 þ / þ animals (yellow areas indicate immobility). Animals that received unpaired treatment did not show learning. Behavioral reaction of both geneotypes to the aversive stimulus was indistinguishable, indicating that the observed augmentation of fear learning in PAR1 À / À mice could not be attributed to altered pain sensitivity (d). The effect of genetic disruption of PAR1 was mimicked by bilateral intra-amygdala injections of PAR1 antagonist SCH79797 during conditioning (e). In a-c n ¼ 11-14 per group; d, e n ¼ 9-10 per group. *Po0.05, **Po0.01, ***Po0.001. Data shown as mean±s.e.m.
wild-type animals that underwent the same treatment. Pain threshold, general motor activity, anxiety and hippocampal functions were indistinguishable between the genotypes (Figure 3d and Supplementary Figure S5 ), indicating that these parameters did not contribute to differences in fear learning.
We next tested if the effect of genetic disruption of the PAR1 gene could be mimicked by its pharmacological inhibition. To this end we bilaterally infused PAR1 antagonist SCH79797 into the amygdala of PAR1 þ / þ mice before conditioning. We found that the enhancement of fear observed in PAR1-deficient animals was recapitulated by pharmacological inhibition of PAR1 in the amygdalae of PAR1 þ / þ mice (Figure 3e and Supplementary Figure S6 ; n ¼ 8-9 per group), indicating that the effect of PAR1 on cued fear learning was amygdala-specific. PAR1-G protein coupling is dynamic, associative and experiencespecific What is the mechanism of the reversal of LTP and enhancement of fear memory following conditioning in PAR1 À / À mice? One possibility is that the G protein-coupling profile of PAR1 and its role in regulating the above phenomena could be dynamic and regulated by fear conditioning. To investigate this hypothesis, we focused on PAR1's association with Ga q/11 and Ga o proteins because they are abundantly expressed in the brain 33, 34 and elicit contrasting effects in the nervous system. 35 To assess whether PAR1-G protein coupling in the amygdala is dynamic and regulated by fear learning, we measured agonist-stimulated [ 35 S]GTPgS binding to G proteins in membrane preparations. By combining this with an immunoprecipitation step we quantified the amount of PAR1 signaling through specific G proteins. 23, 36 The PAR1 agonist TRag stimulated [ 35 S]GTPgS-for-GDP exchange on both Ga q/11 and Ga o proteins in membranes prepared from PAR1 þ / þ , but not PAR1 À / À brain tissue (Figure 4a ; n ¼ 3-5), confirming the protocol's specificity. We found that in the amygdala of fear-naive mice PAR1 was preferentially coupled to 35 S]GTPgS-for-GDP exchange on Ga q/11 was unaltered (92 ± 24% and 105 ± 7% of fear-naive values in the fear-conditioned and unpaired groups, respectively; n ¼ 5 per group), there was a learning-specific two-fold increase in receptormediated [ 35 S]GTPgS binding to Ga o proteins (185 ± 15% and 107 ± 7% of fear-naive values in the fear-conditioned and unpaired groups, respectively; n ¼ 5 per group), demonstrating a selective increase in coupling through this arm of the signaling pathway (Figure 4c) . The above experiments indicate that fear conditioning (but not the unpaired protocol) shifted preferential coupling of PAR1 in the basolateral complex of the amygdala from excitatory Ga q/11 in naive mice towards inhibitory Ga o to suppress fear-induced increases in the activation of principal neurons of basal amygdala (Figure 4d) . Consistent with the previously reported inhibition of cyclic AMP generation by Ga o , 37 we also found an increase in fear-induced CREB (cAMP response element- þ / þ and PAR1 À / À mice 48 h after fear conditioning. Number of action potential spikes was counted as a function of depolarizing current injection (d). Fear conditioning significantly increased action potential firing rate in PAR1 À / À (Po0.01 at 150 pA; Po0.05 at 200 pA). The inset shows a significant increase in the mean input resistance in PAR1
Po0.05). (e) Representative traces of current-clamp recordings at À 40 mV from neurons of naive, unpaired or fear conditioned mice before or after treatment with PAR1 antagonist SCH79797 (1 mM), or agonist TRag (5 mM). In fear-conditioned (but not naive or unpaired) PAR1 þ / þ mice, inhibition of PAR1 with SCH79797 caused an increase, whereas stimulation with TRag elicited a decrease in neuronal firing frequency (individual cells in f and means ± s.e.m. for each group in g). *Po0.05; **Po0.01. (Figure 4e ).
PAR1 regulates neuronal excitability in an experience-dependent manner To investigate the electrophysiological consequences of fearmediated changes in PAR1-G protein coupling that could underlie the reversal of LTP, we subjected PAR1 þ / þ and PAR1 À / À mice to fear conditioning and studied the excitability of principal basal amygdala neurons in current clamp recordings. Two-way analysis of variance revealed a significant genotype Â conditioning interaction on input resistance (F (1, 28) ¼ 5.18; Po0.05; Figure 5d and Supplementary Figure S7D þ / þ animals after fear conditioning.
The neuronal consequences of PAR1-G protein coupling were tested before and after fear conditioning in wild-type amygdala neurons by measuring the change in firing frequency following pharmacological manipulation of PAR1. In naive or unpaired groups, the PAR1 agonist TRag or antagonist SCH79797 elicited mixed inhibitory and excitatory responses, suggesting variable PAR1 coupling to both Ga o and Ga q/11 at single neuron level (Figures 5e-g ). In contrast, after fear conditioning PAR1 agonist elicited a sharp decrease in firing frequency (F (5, 25) ¼ 4.25; Po0.01; n ¼ 5-6 cells per group), supporting the idea of PAR1 switching its coupling to inhibitory Ga o proteins (Figure 4c ). This finding was further corroborated by the PAR1 antagonist triggering an increase in neuronal firing frequency in fearconditioned basal amygdala neurons (Figures 5e-g ). Figure S8 ). In contrast, the AMPA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) completely blocked basal transmission within this pathway (Supplementary Figure S9) . Therefore, to further investigate the electrophysiological mechanism downstream of the fear-mediated G protein switch that could underlie the reversal of L-LTP in PAR1
À / À mice, we examined AMPA-receptor-dependent miniature excitatory postsynaptic currents (mEPSCs) in principal basal amygdala neurons using whole-cell recording. Although we did not detect any differences between the genotypes in fear-naive mice, two-way analysis of variance revealed significant genotype (F (1, 44) 
DISCUSSION
In this study we propose experience-dependent changes in GPCR coupling to G protein subtypes (or 'experience-directed signaling') as a novel form of plasticity in the mammalian brain that results in a fundamental shift in receptor signaling properties. Using PAR1 in a mouse as a model we demonstrated that during fear conditioning GPCR-G protein interactions are dynamic and regulate neuronal excitability, plasticity and learning.
GPCRs have the ability to signal through different G protein subtypes in a ligand-specific manner, a phenomenon called liganddirected trafficking of signaling. 1, 40 Stimulation of serotonin, opioid, vasopressin, dopamine or b-adrenergic receptors with structurally distinct agonists stabilize the receptor in ligand-specific conformations and shifts receptor signaling towards a different G protein and related transduction pathways. 41, 42 Thus, on binding of different pharmacological agents, the same receptor can promote contrasting cellular responses. In our studies we focused on PAR1 for several reasons. First, protease-activated receptors are unique among GPCRs owing to their unusual mode of activation. They can be cleaved by several proteases that produce distinct responses through activation of the same PAR. 43 Thus, this phenomenon might involve selective, protease-dependent coupling of PARs to different G protein(s), thereby promoting different sets of signaling events. Second, various forms of neuronal activity promote the release of different proteases into the extracellular space, [9] [10] [11] [12] 15, 16 suggesting that the type of experience may determine the relative contribution of distinct proteases towards PAR1 cleavage and its association with G protein subtypes. Third, PAR1 is enriched in the amygdala (this paper), suggesting it could be altered during fear conditioning and modulate the expression of fear.
We show here that in response to fear conditioning, PAR1 receptors in the basolateral complex of the amygdala shift their G protein coupling profile to regulate neuronal plasticity, excitability and memory of traumatic experience. Fear conditioning 'reprograms' PAR1 receptors, which can activate both Ga q/11 and Ga o proteins, shifting their G protein-coupling preference more towards Ga o and inhibiting neuronal excitability, activity and synaptic plasticity. Consequently, stimulation of PAR1 before and after fear conditioning elicits opposite effects on neuronal activity in the basal amygdala, an increase in neuronal firing frequency in fear-naive and a decrease in fear-conditioned animals. Thus, the PAR1-G protein switch serves as an experience-specific, ultrashort negative-feedback loop operating at a subcellular level to finetune neuronal activity underlying formation of traumatic memories. Consequently, PAR1
À / À mice show lower L-LTP before and enhanced L-LTP after fear conditioning, consistent with the disruption of the dynamic, PAR1-dependent G protein coupling regulating neuronal activity and plasticity.
It has been shown in various systems that activation of PAR1 by different proteases (or a different concentration of the same protease) often results in contrasting physiological outcomes. 8 Opposite effects of low versus high doses of the PAR1 agonist thrombin have been observed in both the nervous system and other tissues. Liberation of excessive amounts of the protease (or an entirely different set of proteases) from presynaptic terminals in response to strong stimuli may result in the loss of substrate specificity and subsequent cleavage of PAR1 at low-affinity (or, in case of other proteases, entirely new) cleavage sites. Moreover, different sets of environmental stimuli liberating different 'protease cocktails' into the amygdala synapses through a variety of neuronal projections would leave their unique, experience-specific 'cleavage footprints' on PAR1 (and/or its molecular partners) and may determine its G protein-coupling characteristics. Such a mechanism would provide a dynamic and precise control of GPCR/G protein coupling in response to different stimulus potencies and contingencies. This hypothesis is supported by our study (enhancement of fear learning in PAR1 À / À mice following a mild conditioning protocol) and that of Almonte et al. (impairment of fear responses in PAR1 À / À animals following a strong fear-conditioning protocol). 13 Such a hypothesis is also in agreement with previous reports indicating that the strength of fear memories does not always correlate with training intensity, but often follows a non-linear model. 44 In spite of the involvement of G proteins and GPCRs in various forms of learning in a variety of species, the dynamic nature of experience-driven GPCR-G protein coupling has, to our knowledge, never been demonstrated. Although it has been shown that another GPCR, corticotropin-releasing factor receptor, differentially regulates conditioned fear responses in C57BL/6N and BALB/ c mouse strains by coupling to distinct sets of G proteins, it was unclear whether receptor-G protein coupling was static or dynamic. 45 Other studies have found that perturbing cyclic AMP signaling by expression of the constitutively active form of Ga s in forebrain neurons leads to learning impairment, as well as to a number of schizophrenia-related phenotypes. 46, 47 Recent studies in mice using genetically engineered and light-activated GPCRs elegantly showed that selective activation of distinct intracellular signaling cascades in the nucleus accumbens elicits contrasting reward-related behaviors in the conditioned place preference paradigm. 6 Altogether, the above experiments indicate that experience-specific shift in the GPCR-G protein coupling could control multiple aspects of synaptic plasticity associated with emotionality and learning in mammals.
Previous studies have shown PAR-1 could regulate the Nmethyl-D-aspartate receptor function. 48 However, to our knowledge the mechanism of action of PAR-1 in the amygdala has never been studied and it is likely pathway-specific. The mechanism of action of PAR-1 may depend on regional differences in its modulatory signaling components (for example, the expression, alternative splicing or post-translational modifications of PAR-1, other PARs, their putative activating proteases or protease inhibitors).
In summary, our previous and current data support a model where PAR-1 G protein switch serves as a buffering system protecting against the development of traumatic memories in response to weak (that is, insignificant) aversive encounters. In response to an aversive experience, plasticity-related proteases are liberated into amygdala synapses 9, 11 to cleave PAR1. This cleavage changes PAR1-G protein coupling preference towards Ga o . Subsequently, the shift in the G protein association affects AMPA-mediated responses and neuronal excitability. In PAR1 þ / þ animals the effects of this modified G protein coupling could be counterbalanced by simultaneous adjustments of other receptor systems. The physiological and behavioral consequences of these adjustments are rapidly exposed in PAR1
À / À mice, where fear conditioning affects synaptic transmission and plasticity, whereas these parameters are largely unaffected in PAR1 þ / þ animals. These changes manifest themselves as enhanced L-LTP, fear learning, neuronal excitability and AMPA-mediated responses in PAR1 À / À mice, consistent with the lack of PAR1-evoked, Ga omediated inhibition.
The above mechanism has a significant translational potential. First, defective functioning of the PAR1/G protein buffering system (as a result of mutations in the PAR-1/G-protein machinery or their molecular partners) may lead to predisposition to the development of stress-related psychiatric disorders in response to mild trauma. Identification of the underlying mutations may open new avenues for treatment/prevention of anxiety disorders (including the post-traumatic stress disorder) or depression. Underlying defects could potentially be corrected by locking GPCR in a desired G-protein coupling state using biased ligands (see Rajagopal et al. 49 ). Given the plethora of GPCRs in the central nervous system and their diverse mechanisms of activation, it is likely that distinct sensory or emotional states could create their unique, experiencespecific 'biochemical footprints' across the brain through exclusive GPCR-G protein effector coupling profiles. Such a mechanism would provide both a flexible and a precise means of controlling other aspects of animal behavior.
